Article
A model to predict the response to therapy against hepatitis C virus (HCV) including low-density lipoprotein receptor genotype in HIV/HCV-coinfected patients.
The Journal of antimicrobial chemotherapy - 1 Apr 2013
Neukam Karin, Almeida Carmen, Caruz Antonio, Rivero-Juárez Antonio, Rallón Norma I, Di Lello Federico A, Herrero Rocío, Camacho Angela, Benito José M, Macías Juan, Rivero Antonio, Soriano Vicente, Pineda Juan A
Abstract excerpt
OBJECTIVES: Accurate prediction of sustained virological response (SVR) to pegylated interferon-α (Peg-IFN) plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients could improve the management of these patients. We aimed to develop a model to predict SVR to Peg-IFN/ribavirin in HIV/HCV-coinfected individuals combining HCV genotype and baseline HCV RNA load with interleukin 28B and low-density...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.